Showing results (1041-1050 of 1,091) with videos related to

Sort By:
Pageof 110
Pediatric Research|May 2, 2026
Pediatric SARS-CoV-2 outcomes study (PECOS): 12-month longitudinal analysis of post-COVID symptoms in infected versus uninfected participantsGina A Montealegre Sanchez, Alexandra B Yonts, Allyson Mateja, et al.
Pediatrics|July 3, 2020
Reducing Vancomycin Use in a Level IV NICURana F Hamdy, Sopnil Bhattarai, Sudeepta K Basu, et al.
Molecular Therapy. Nucleic Acids|July 12, 2023
Nanoblades allow high-level genome editing in murine and human organoidsVictor Tiroille, Adrien Krug, Emma Bokobza, et al.
Emergency Medicine Australasia : EMA|November 25, 2015
Best-practice pain management in the emergency department: A cluster-randomised, controlled, intervention trialDavid McD Taylor, Daniel M Fatovich, Daniel P Finucci, et al.
RMD Open|January 22, 2026
Impact of ANCA specificity on risk of cardiovascular events and death in ANCA-associated vasculitisJon Idoate Lacasia, Morgane Mourguet, Thomas Villeneuve, et al.
Molecular Cancer Therapeutics|September 3, 2009
Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myelomaFrits van Rhee, Susann M Szmania, Myles Dillon, et al.
Nature Communications|March 6, 2021
Deciphering the state of immune silence in fatal COVID-19 patientsPierre Bost, Francesco De Sanctis, Stefania Canè, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2008
Southern Ocean frontal structure and sea-ice formation rates revealed by elephant sealsJ-B Charrassin, M Hindell, S R Rintoul, et al.
Communications Biology|March 2, 2022
Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotidesJeremy P Bost, Miina Ojansivu, Michael J Munson, et al.
Haematologica|March 16, 2012
Highly activated and expanded natural killer cells for multiple myeloma immunotherapyTarun K Garg, Susann M Szmania, Junaid A Khan, et al.
Pageof 110